Jessica Yang Selected Research

Immunotherapy

11/2022	DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response.
11/2022	Immune Checkpoint Blockade and Targeted Therapies in Esophageal Cancer.
11/2019	Novel Targets for the Treatment of Melanoma.
1/2016	Clinical Management of Uveal and Conjunctival Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica Yang Research Topics

Disease

8	Neoplasms (Cancer) 04/2024 - 01/2018
5	Breast Neoplasms (Breast Cancer) 11/2022 - 06/2015
4	Triple Negative Breast Neoplasms 04/2024 - 01/2020
4	Melanoma (Melanoma, Malignant) 01/2020 - 01/2016
3	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2018
3	Uveal melanoma 10/2022 - 01/2016
2	Neuroblastoma 05/2024 - 01/2022
2	Adenocarcinoma 10/2023 - 11/2022
2	Carcinogenesis 01/2022 - 06/2015
2	Disease Progression 11/2019 - 03/2011
1	Colorectal Neoplasms (Colorectal Cancer) 03/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023
1	Pathologic Complete Response 06/2023
1	Stomach Neoplasms (Stomach Cancer) 06/2023
1	Pseudomyxoma Peritonei 01/2023
1	Fahr's disease 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Hypoparathyroidism 01/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2023
1	Pseudohypoparathyroidism 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Wounds and Injuries (Trauma) 05/2012
1	Fucosidosis 03/2011

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 05/2024 - 06/2015
4	NivolumabIBA 10/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2015
3	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2016
2	Phosphotransferases (Kinase)IBA 03/2024 - 01/2021
2	pembrolizumabIBA 11/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	IpilimumabIBA 01/2020 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	tyrosine receptor (receptor, tyrosine)IBA 03/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	regorafenibIBA 10/2023
1	Trinitrotoluene (TNT)IBA 06/2023
1	bromelain and acetylcysteine drug combinationIBA 01/2023
1	vedolizumabIBA 01/2023
1	CalciumIBA 01/2023
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2023
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2023
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	tebentafuspIBA 10/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2021
1	BLU9931IBA 01/2021
1	Inhibitor of Differentiation Protein 1IBA 01/2020
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	taxaneIBA 01/2018
1	LigandsIBA 01/2018
1	Fibrillar CollagensIBA 01/2018
1	cabazitaxel FDA Link 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2016

Therapy/Procedure

13	Therapeutics 03/2024 - 03/2011
5	Drug Therapy (Chemotherapy) 10/2023 - 01/2018
4	Immunotherapy 11/2022 - 01/2016
1	Duration of Therapy 03/2024
1	Neoadjuvant Therapy 06/2023
1	Precision Medicine 01/2023
1	Traction 01/2023
1	Castration 01/2018
1	Length of Stay 05/2012